What to Know about Those Vaccines

2020-11-20 · 22 min · episode 610 · 12 entities

episode page audio

Asserted relationships

→ appeared on The a16z Show podcast

0.63 · ×2

evidence rules-v4
What to Know about Those Vaccines
→ hosted by Andreessen Horowitz person

0.55 · ×2

evidence rules-v4
Feed author/publisher: Andreessen Horowitz
→ discusses Business company

0.40 · ×2

evidence rules-v4
Feed category: Business
→ discusses Technology company

0.40 · ×2

evidence rules-v4
Feed category: Technology
→ discusses Entrepreneurship website

0.40 · ×2

evidence rules-v4
Feed category: Entrepreneurship
→ discusses Science concept

0.40 · ×2

evidence rules-v4
Feed category: Science
→ hosted by a16z company

0.40 · ×2

evidence rules-v4
Feed author/publisher: a16z

Entities found in this episode

companys 5

mentioned Business company

0.50 · ×2

evidence rules-v4
Feed category: Business
mentioned Technology company

0.50 · ×2

evidence rules-v4
Feed category: Technology
discusses Business company

0.40 · ×2

evidence rules-v4
Feed category: Business
discusses Technology company

0.40 · ×2

evidence rules-v4
Feed category: Technology
hosted by a16z company

0.40 · ×2

evidence rules-v4
Feed author/publisher: a16z

persons 2

mentioned Andreessen Horowitz person

0.70 · ×2

evidence rules-v4
Feed author/publisher: Andreessen Horowitz
hosted by Andreessen Horowitz person

0.55 · ×2

evidence rules-v4
Feed author/publisher: Andreessen Horowitz

websites 2

mentioned Entrepreneurship website

0.50 · ×2

evidence rules-v4
Feed category: Entrepreneurship
discusses Entrepreneurship website

0.40 · ×2

evidence rules-v4
Feed category: Entrepreneurship

concepts 2

mentioned Science concept

0.50 · ×2

evidence rules-v4
Feed category: Science
discusses Science concept

0.40 · ×2

evidence rules-v4
Feed category: Science

podcasts 1

appeared on The a16z Show podcast

0.63 · ×2

evidence rules-v4
What to Know about Those Vaccines

Episode description as stored

A vaccine for COVID seems to be (almost) here… or is it? What’s hype/ what’s real beyond the headlines (and beyond the press release), when it comes to the announcement last week from Pfizer and BioNTech that their vaccine candidate was found to be more than 90% effective in preventing COVID-19 -- and relatedly, the most recent news around Moderna's vaccine candidate? Of course, this was just the first interim efficacy analysis — so how close or far are we? What’s the significance of the readout and case numbers? How do we put all this in context of all the other (458!) programs in development? And how much should/ shouldn’t we read into the news, given the buzzy excitement and penchant for evaluating "science via press release"? a16z bio general partners Vineeta Agarwala and Jorge Conde recently broke it all down in conversation with Sonal Chokshi on our show 16 Minutes: the math, the science, and the practical considerations — from “vaccine efficacy” vs. efficiency, from cold chains to distribution, from patients to the system… as well as why mRNA matters in the present future of vaccines. Stay Updated: Find a16z on YouTube: YouTube Find a16z on X Find a16z on LinkedIn Listen to the a16z Show on Spotify Listen to the a16z Show on Apple Podcasts Follow our host: https://twitter.com/eriktorenberg Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.